Search for: "No. 337" Results 2521 - 2540 of 4,432
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Jun 2011, 5:00 am by Kimberly A. Kralowec
Fund, 511 U.S. 328, 337 (1994) (“[I]t is the statute, and not the [voter’s findings], which is the authoritative expression of the law . . . . [read post]
1 Jun 2011, 5:16 pm by Eric Schweibenz
On May 31, 2011, X2Y Attenuators, LLC of Erie, Pennsylvania (“X2Y”) filed a complaint requesting that the ITC commence an investigation pursuant to Section 337. [read post]
1 Jun 2011, 9:29 am
Statewide only 337 citations have been issued to drivers who passed too closely--only 15 of those in Palm Beach County. [read post]
30 May 2011, 4:55 am by Marie Louise
LLC (Chicago IP Litigation Blog)   US Patents – Lawsuits and strategic steps Duggal – ALJ Gildea rules on motions in Certain Wind And Solar-Powered Light Posts And Street Lamps (337-TA-736), respondents’ motion for summary determination of invalidity denied (ITC Law Blog) OptiGen – Sanctions backfire: Defendant’s baseless requests for Rule 11 sanctions may lead to sanctions against defense counsel: OptiGen v Animal Genetics (Docket Report) Otter –… [read post]
27 May 2011, 7:09 am by Eric Schweibenz
On May 25, 2011, Otter Products, LLC of Fort Collins, Colorado (“Otter”) filed a complaint requesting that the ITC commence an investigation pursuant to Section 337. [read post]
26 May 2011, 10:58 pm by Marie Louise
TiVo Inc (Docket Report) Omga – ALJ Gildea sets target date in Certain Motion-Sensitive Sound Effects Devices and Image Display Devices (337-TA-773) (ITC Law Blog) Oracle – Google off to good start in reexamination of Oracle patents (WHDA) Siemens Corp – ALJ Luckern grants non-party motion to quash in Certain Wireless Communication Devices, Portable Music and Data Processing Devices (337-TA-745) (ITC Law Blog) Verizon – ALJ Gildea issues initial… [read post]
25 May 2011, 4:59 am by Marie Louise
(Kluwer Patent Blog) USPTO statement at WIPO side event on Medicines Patent Pool (Knowledge Ecology International) US: To implement health reform orphan drug exclusion, HRSA issues first-ever proposed regulation on 340B drug discount program (FDA Law Blog) US: FDA officials hint at provisions of biosimilar guidances (Patent Docs) US: Huffington Post: Data Exclusivity: Getting the balance right (PatentlyBIOtech) US: Report gauges economic impact of Human Genome Project (Patent Docs) US: Chairman… [read post]